Get started
Dr. Reddy's Laboratories Ltd. Sponsored ADRDr. Reddy's Laboratories Ltd. Sponsored ADRDr. Reddy's Laboratories Ltd. Sponsored ADR

Dr. Reddy's Laboratories Ltd. Sponsored ADR

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsForecastSeasonalsETFs

RDDA trade ideas

DRREDDY–Weekly Chart AnalysisThe stock is currently trading near ₹1,322 and is once again testing the long-term descending trendline resistance that has capped every rally since 2023. This resistance lies in the ₹1,345–₹1,348 zone and represents the key decision point for the next move. Bullish Scenario (if breakout holds) First method of calculation: ₹1,379.70, 1398.25, 1415-1421 → derived from prior swing highs. Second method : ₹1,705→ based on a range of neckline to head of inverted head & shoulder. This is not a valid setup. Third method : ₹1,472, 1,530, 1585→ calculated as fib extension levels. Bearish Scenario (if rejection occurs) Support: ₹1284, 1245, 1200 as immediate downside levels. Momentum RSI is around 58, showing a bullish curve without overbought conditions, suggesting momentum supports an upside breakout.
NSE:DRREDDYLong
by AbsoluteAnalytics
DRREDDY Bullish ProjectionMETHODOLOGY SUMMARY Mathematical Transformation: Uses square root, cube root, and 4th root of price to identify natural support/resistance levels Perfect Level Calculation: Round roots to nearest integer, then power back to create "perfect" mathematical anchors Multi-Timeframe Analysis: Square Root: Short-term cycle (days-weeks 3-5%) Cube Root: Medium-term cycle (weeks-months 5-12%) 4th Root: Long-term structural cycle (months-quarters 12-18%) Current DRREDDY Analysis: Price: ₹1,305.70 4th Root Level: ₹1,296 ✅ CROSSED ABOVE Cube Level: ₹1,331 (Next resistance) Square Level: ₹1,296 (Confluence support) TRADE SETUP Entry Strategy: Primary Entry: ₹1,305-1,310 (Current levels) Add-on Entry: ₹1,296-1,300 (4th root support retest) Targets: Target 1: ₹1,331 (Cube level) - Book 25% quantity Target 2: ₹1,370 (Next mathematical resistance) - Book 75% quantity Extended Target: ₹2,401 (Next 4th power level) Stop Loss: Conservative: ₹1,285 (Below 4th root with buffer) Aggressive: ₹1,276 (2% below 4th root level) Risk-Reward: R:R Ratio: 1:3.2 (to Target 2) Position Size: 1-2% of portfolio risk Why This Setup Works: Mathematical Precision: 4th root levels act as major structural pivots derived from natural number theory Cross Confirmation: Price breaking above ₹1,296 (4th root) suggests longer-term cycle shift Volume Confluence: Breakout supported by institutional accumulation Sector Strength: Pharma sector showing resilience Key Levels Explanation: ₹1,296: 11^4 = 14,641 → ∜14,641 ≈ 11 → 11^4 = 1,296 (4th root anchor) ₹1,331: 11^3 = 1,331 (Cube resistance) ₹2,401: 7^4 = 2,401 (Next 4th power level up) Market Psychology: Below 4th Root: Institutional distribution phase Above 4th Root: Institutional accumulation begins Above Cube: Momentum acceleration phase Invalidation Scenarios: Break below ₹1,285 with volume Failure to hold above ₹1,296 for 2+ sessions Broader market correction below key supports Time Frame: 2-4 weeks for Target 1, 6-8 weeks for Target 2 Disclaimer: lnkd.in
NSE:DRREDDY
by ALICEBLUE
Dr. Reddy's (Weekly Timeframe) - Potential BreakOut?Dr. Reddy's Laboratories is currently in a phase of strategic consolidation. After a remarkable 93.63% uptrend that began in March 2022, the stock has settled into a well-defined triangle formation since August 2024. This pattern suggests a temporary equilibrium between buyers and sellers as the market digests previous gains. The technical underpinnings remain constructive. The Positive Crossover (PCO) in the short-term EMAs provides a bullish undercurrent, and the resilience of key support levels indicates a solid foundation. The primary scenario we are monitoring is for a bullish continuation. The key catalyst for the next leg up will be a volume-supported breakout above the triangle's resistance. Such a move would signal the end of the consolidation phase and could propel the stock towards retesting its All-Time High (ATH) . Investors should, however, remain watchful of the trading volume, as it will be the ultimate arbiter of the breakout's validity.
NSE:DRREDDY
by Learn_with_Pth0mas
NSE:DRREDDY - Medium Term Swing Trade Opprotunity💹 Weekly Charts:: Price is consolidating around ₹1,300 after a bounce from the ₹1,150–1,180 zone (strong support zone). Major resistance levels: ₹1,350–1,360 (R1 zone & trendline resistance) ₹1,415 (swing high and R2 zone) Weekly RSI ~60, showing improving momentum but not yet overbought. MACD histogram turning positive → suggests early signs of bullish momentum. 📊 Daily Charts:: Price recently broke above ₹1,244–1,250 zone, now retesting near ₹1,300–1,307 (R1 pivot resistance). Next resistance: ₹1,350–1,360, followed by ₹1,410–1,415. RSI ~65, bullish but near overbought → breakout confirmation is key. ADX improving, +DI > -DI → trend strengthening. Volume is moderate but picking up on green candles. 📈 Upside Potential:: If price sustains above ₹1,310, it can rally towards: ₹1,350–1,360 (short-term target) ₹1,415 (swing high) Breakout above ₹1,415 on strong volume → opens potential towards ₹1,505–1,520 (weekly R2 & psychological round level). 📉 Downside / Risk Levels:: Strong support: ₹1,245–1,250 (previous breakout zone). Deeper support: ₹1,180–1,200 (weekly support + P pivot). If price breaks below ₹1,180, bearish momentum may resume towards ₹1,100. ✅ Conclusion Worth initiating a long only if it sustains above ₹1,310 with good volume. Upside potential: ~8–15% (₹1,360 to ₹1,415, and possibly ₹1,500). Stop-loss: Below ₹1,245 on a closing basis (or tighter at ₹1,275 if risk needs to be managed). This is a medium-term swing trade opportunity. 🛄 Disclaimer: This idea is posted solely for educational and learning purposes only and must not be construed as advice to buy or sell. Please consult your investment advisor before making any financial decision. Investments are subject to market risks.
NSE:DRREDDYLong
by TheWealthVector
DR REDDY VCPStock is forming a classic Volatility Contraction Pattern (VCP) on the daily chart. Each consolidation is getting tighter, showing supply absorption. Volume is drying up on pullbacks, while demand is visible on upswings. ✅ Strong pharma sector tailwinds (export + domestic) ✅ Macro catalysts: global drug shortages, and India’s role as a low-cost supplier ✅ Technicals: Breakout level around ₹1280/-, with stop below the last contraction low If the breakout sustains with volume, could lead to a strong momentum move 🚀.
NSE:DRREDDYLong
by khilesh_k
Dr. Reddy’s at Critical Zone – Double Top + Wedge Breakdown Dr. Reddy’s Laboratories Ltd. (1H Timeframe) – Price Action & Structure The stock is currently trading around ₹1,256, facing strong supply pressure from the ₹1,280–₹1,300 OrderBlock zone. A Rising Wedge pattern was formed during the recent uptrend, which usually indicates trend exhaustion and potential reversal. The wedge breakdown has already happened, and price failed to reclaim the upper boundary, confirming bearish intent. A Double Top formation (Top1 & Top2) inside the OrderBlock further validates the sellers’ dominance. Bearish Signals :- Multiple Rejections at Order-Block: Sellers are strongly defending the ₹1,300 level. Pattern Confirmation: Rising Wedge + Double Top = High probability bearish setup. Momentum Shift: Lower highs and breakdown of trendline support show loss of bullish strength. Volume Behavior: Increased volume on red candles signals institutional selling. Trade Setup :- Entry Zone: Breakdown confirmation below ₹1,260. Stop Loss: Above ₹1,310 (order block invalidation). Target 1: ₹1,210 (minor support). Target 2: ₹1,152 (major support, projected move completion). Risk–Reward Ratio: Around 1:2.5 to 1:3, favorable for swing positioning. Key Insights for Traders:- As long as the price stays below ₹1,290–1,300, short positions remain valid. If buyers push price back above ₹1,310, bearish setup will get invalidated
NSE:DRREDDYShort
by Yugal
DRREDDYDRREDDY - The stock is showing strength as it trades above all the key EMAs, indicating bullish momentum. A clear volume pickup is visible, adding confirmation to the move. After a healthy retracement, price has broken above the immediate resistance zone. If it sustains this breakout, there’s a strong probability of an extended upside move. The last hammer candle took solid support at the 200 EMA, which often acts as a major trend indicator, this bounce further validates the underlying strength. Defining stop-loss and position sizing is crucial to manage downside risk, even in strong setups. ✅ If you like my analysis, please follow me as a token of appreciation :) in.tradingview.com/u/SatpalS/ 📌 For learning and educational purposes only, not a recommendation. Please consult your financial advisor before investing.
NSE:DRREDDY
by SatpalS
Dr Reddy : LongDR. Reddy’s Laboratories is showing a falling wedge pattern, which is typically considered a bullish reversal signal. EMA Analysis: The price is trading above the 10, 20, and 200 EMAs, confirming the short-, medium-, and long-term bullish trend. A successful breakout above the descending trendline increases confidence in a sustained upward move. The recent crossover of 10 EMA above the 20 EMA further strengthens bullish momentum. Volume Analysis: Bullish candles during the breakout phase are supported by rising volumes, indicating robust buying interest and solidifying the validity of the breakout. Volumes have reached above 430K, notably higher than previous averages, suggesting institutional participation. RSI Analysis: The RSI is at 59.78, positioned securely above the midline (50) but still below any overbought condition (70). This level demonstrates enough momentum for further upside, leaving room for the rally to extend before any corrective move. Trade Setup Recommendation Parameter Value/Action Entry: Above ₹1,285 after confirmation Stop Loss: Below ₹1,265 (below breakout low/EMAs) Target 1: ₹1,295–₹1,310 (near-term resistance) Target 2: ₹1,340 (extension, if momentum holds) RSI Condition: Hold as long as RSI remains < 70 Buy on confirmation above ₹1,285 with the given stop loss and targets; volumes and RSI both support entry at current levels. If price closes below the 200 EMA or RSI falls below 50, reconsider the bullish trade. This setup leverages strong technical signals and is suitable for short- to medium-term trading. The analysis and trade setup provided above are for educational purposes only and do not constitute investment advice. Always conduct independent research, consider personal financial circumstances, and consult with a qualified financial advisor before making trading or investment decisions. Trading stocks and financial instruments involve risks, including the possibility of losing capital, and past performance does not guarantee future results
NSE:DRREDDYLong
by PowerOfTA
DRREDDY – Triangle Breakout in Play📊 DRREDDY – Technical & Educational Snapshot Ticker: NSE: DRREDDY | Sector: 💊 Pharma CMP: ₹1,276.60 ▲ (+2.51% | 22 Aug 2025) Rating (for learning purpose): ⭐⭐⭐⭐ (Moderately Bullish) Pattern Observed: 📈 Triangle Breakout with Volume Confirmation 📰 Sentiment Analysis 👉 Overall Sentiment: Positive ✅ • Bullish Drivers: Breakout from triangle formation, Morning Star on daily, bullish PinBar on monthly, strong Q1 results with revenue & profit growth, and renewed interest in pharma sector due to healthcare demand. • Risks (Bearish Case): Any failure to sustain above ₹1,250 or renewed pressure from regulatory issues/patent challenges could trigger pullbacks. • Short-term Outlook: Strong breakout with momentum, but some cooling-off likely due to Stochastic overbought levels. • Long-term Outlook: Positive — consistent financial performance, strong pharma pipeline, and robust technical structure suggest higher upside potential. 📊 Technical Snapshot DRREDDY has broken out from a triangle formation, supported by a Morning Star candlestick on the daily timeframe and a Bullish PinBar on the monthly chart — both strong reversal cues. A bullish Supertrend, RSI breakout, and Bollinger Band expansion signal renewed buying interest. Volume above the 20-SMA average further validates the breakout, suggesting institutional participation. While momentum is strong, Stochastic is near overbought, which means short-term pullbacks cannot be ruled out. However, as long as price sustains above key support zones, the broader trend bias remains upward. 📊 Volume Check 🔹 Current Volume: 2.01M 🔹 20 SMA Volume: 1.61M ✅ 💥 Above-average participation → confirms breakout reliability with demand expansion. 💡 Interpretation: Higher-than-average volumes in breakout zones indicate broader market participation and improve the chances of trend continuation. 💡 Learnings Breakouts from consolidation patterns like triangles tend to extend into trending moves when supported by momentum indicators (RSI + MACD). Elevated CCI levels indicate consistent buying pressure, but traders should remain alert to possible short pullbacks, especially when Stochastic enters the overbought zone. Defining a stop-loss and invalidation level is key for disciplined trade management. 📌 Key Levels Resistance: 1292 | 1308 | 1334 Support: 1251 | 1225 | 1209 Fibonacci Levels: 1138.50 | 1195.40 | 1230.65 | 1259.10 | 1287.55 | 1328.10 | 1379.70 🎯 STWP Learning Reference • Observed breakout zone: ~1281.8 • Key support level: ~1236 • Upside reference zones (if momentum continues): 1327 | 1372 • Pullback watch zone: 1224–1230 (where demand has earlier emerged) • Invalidation reference: Below 1195 (trend may weaken) ⚠️ Disclaimer – Please Read Carefully The information shared here is meant purely for learning and awareness. It is not a buy or sell recommendation and should not be taken as investment advice. I am not a SEBI-registered investment advisor, and all views expressed are based on personal study, chart patterns, and publicly available market data. Trading — whether in stocks or options — carries risk. Markets can move unexpectedly, and losses can sometimes exceed the money you have invested. Past performance or past setups do not guarantee future results. If you are a beginner, treat this as a guide to understand how the market works — practice on paper trades before risking real money. If you are experienced, always assess your own risk, position sizing, and strategy suitability before entering trades. Consult a SEBI-registered financial advisor before making any real trading decision. By engaging with this content, you acknowledge full responsibility for your trades and investments. 💬 Found this useful? 🔼 Give this post a Boost to help more traders discover clean, structured learning. ✍️ Drop your thoughts, questions, or setups in the comments — let’s grow together! 🔁 Share with fellow traders and beginners to spread awareness. ✅ Follow simpletradewithpatience for beginner-friendly setups, price action insights & disciplined trading content. 🚀 Stay Calm. Stay Clean. Trade With Patience. Trade Smart | Learn Zones | Be Self-Reliant 📊
NSE:DRREDDYLong
by simpletradewithpatience
Dr. Reddy’s – A Healthy Dose of GrowthFundamental Overview Dr. Reddy’s Laboratories Ltd. (NSE: DRREDDY) is one of India’s leading pharmaceutical companies with a strong global presence across generics, active pharmaceutical ingredients (APIs), biosimilars, and specialty medicines. The company’s diversified portfolio across the U.S., India, Russia, and emerging markets helps cushion against regional risks. Financial Highlights (FY 2024–25) Revenue Growth: Consistent YoY revenue expansion driven by strong U.S. generics sales and India formulations. Profitability: Robust EBITDA margins supported by cost optimization and efficient R&D allocation. R&D Spending: Around 7–8% of revenue, strengthening the pipeline for complex generics and biosimilars. Debt Profile: Very low leverage with strong cash flows, providing balance sheet resilience. Key Ratio Metrics P/E Ratio: ~20.5 (reasonable vs. sector average ~24). P/B Ratio: ~4.2 (slightly premium, reflecting brand strength and consistent profitability). ROE: ~17.4% (efficient capital utilization). ROCE: ~20% (solid operational performance). Debt-to-Equity: ~0.05 (nearly debt-free). Operating Margin: ~24% (healthy compared to peers). Fundamental Sentiment: Positive — strong balance sheet, high return ratios, and steady global presence make Dr. Reddy’s a long-term compounding story. Sentimental Analysis US Tariff Policy Impact The recent U.S. administration discussions on drug pricing reforms and import tariffs have mixed implications. While tariff hikes on Chinese raw materials increase input costs, Indian pharma companies like Dr. Reddy’s can benefit from being an alternate sourcing hub. U.S. remains the largest revenue contributor (~40%), so regulatory/tariff relief on generics is a net positive. Technical Insights 200 SMA Support: Price has reclaimed the 200-day SMA (~₹1,238), signaling a trend reversal. Parallel Channel Breakout: Breakout from the downward channel suggests a bullish reversal. Demand Zone: Weekly demand zone at ₹1,129–₹1,189 provided strong accumulation support. Reversal Zone: ₹1,204–₹1,238 aligned with the 200 SMA acted as a crucial pivot zone. Volume Action Latest Volume: 2.01M shares 30-Day Average Volume: 1.42M shares The 40% higher-than-average volume confirms institutional participation and validates the breakout. Key Resistance Levels R1: ₹1,334 R2: ₹1,378 R3: ₹1,453 Technical Sentiment: Bullish momentum supported by above-average volume. Sustained close above ₹1,283 can trigger the next rally. Conclusion Dr. Reddy’s Laboratories stands out as a fundamentally strong and technically improving stock. With robust financials, negligible debt, consistent R&D spending, and favorable sentiment from U.S. tariff realignments and GST clarity, the company is well positioned for sustainable growth. Short-term View: Bullish above ₹1,283 with targets of ₹1,334–₹1,453. Long-term View: Strong fundamentals make it a compounding story in the Indian pharma sector. Disclaimer: lnkd.in
NSE:DRREDDY
by ALICEBLUE
Dr. Reddy’s Breakout + Bullish Stochastic + Volume Surge = ₹1307🔍 TECHNICAL HIGHLIGHTS: 📉 DESCENDING WEDGE BREAKOUT: Price has decisively broken above the wedge resistance, signaling a trend reversal. 🚀 GAP-UP OPENING: Signals aggressive buyer interest and bullish sentiment. 🔄 STOCHASTIC OSCILLATOR: Fast %K line has crossed above the slow %D line in the oversold zone, indicating momentum is shifting to the upside. 🔊 VOLUME SURGE: Heavy volume during breakout confirms strong buying pressure and likely institutional participation. 🎯 TRADE SETUP: ✅ PROFIT TARGET : ₹1307 ❌ STOP LOSS: ₹1221 📌 CONCLUSION: All indicators align for a potential bullish rally. With pattern confirmation, momentum support, and volume validation, this setup looks promising. Watch for follow-through price action and volume consistency.
NSE:DRREDDYLong
by peace_lover
1
DR REDDY S LABORATORIESAs of June 6, 2025, Dr. Reddy's Laboratories Ltd. (NSE: DRREDDY) is trading at approximately ₹1,290.60, reflecting a 3.04% increase over the previous day. 📊 Daily Pivot Points (Classic Method) Based on the previous day's high, low, and close, the daily pivot levels are: Pivot Point: ₹1,307.93 Support Levels: S1: ₹1,286.07 S2: ₹1,268.73 S3: ₹1,246.87 Resistance Levels: R1: ₹1,325.27 R2: ₹1,347.13 R3: ₹1,369.99 📈 Fibonacci Pivot Points Using Fibonacci calculations, the levels are: Pivot Point: ₹1,307.93 Support Levels: S1: ₹1,286.07 S2: ₹1,268.73 S3: ₹1,246.87 Resistance Levels: R1: ₹1,325.27 R2: ₹1,347.13 R3: ₹1,369.99 🔍 Camarilla Pivot Points Derived using the Camarilla method: Pivot Point: ₹1,286.07 Support Levels: S1: ₹1,269.04 S2: ₹1,279.82 S3: ₹1,283.41 Resistance Levels: R1: ₹1,294.19 R2: ₹1,297.79 R3: ₹1,301.38 📌 Trading Insights Immediate Support: ₹1,286.07 (Classic S1) Immediate Resistance: ₹1,325.27 (Classic R1) Traders may consider these levels for setting stop-loss and take-profit orders. A break above ₹1,325.27 could signal bullish momentum, while a drop below ₹1,286.07 might indicate bearish pressure.
NSE:DRREDDYLong
by TechnicalExpress